Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

A retrospective multisite examination of depression screening practices, scores, and correlates in pediatric diabetes care.

Mulvaney SA, Mara CA, Kichler JC, Majidi S, Driscoll KA, Westen SC, Rawlinson A, Jacobsen LM, Adams RN, Hood KK, Monaghan M.

Transl Behav Med. 2019 Nov 25. pii: ibz171. doi: 10.1093/tbm/ibz171. [Epub ahead of print]

PMID:
31764981
2.

Depression in context: Important considerations for youth with type 1 vs type 2 diabetes.

Wong JJ, Addala A, Abujaradeh H, Adams RN, Barley RC, Hanes SJ, Iturralde E, Lanning MS, Naranjo D, Tanenbaum ML, Hood KK.

Pediatr Diabetes. 2019 Oct 23. doi: 10.1111/pedi.12939. [Epub ahead of print]

PMID:
31644828
3.

Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial.

Athinarayanan SJ, Adams RN, Hallberg SJ, McKenzie AL, Bhanpuri NH, Campbell WW, Volek JS, Phinney SD, McCarter JP.

Front Endocrinol (Lausanne). 2019 Jun 5;10:348. doi: 10.3389/fendo.2019.00348. eCollection 2019.

4.

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study.

Vilar-Gomez E, Athinarayanan SJ, Adams RN, Hallberg SJ, Bhanpuri NH, McKenzie AL, Campbell WW, McCarter JP, Phinney SD, Volek JS, Chalasani N.

BMJ Open. 2019 Feb 25;9(2):e023597. doi: 10.1136/bmjopen-2018-023597.

5.

Targeting the third '90': introducing the viral load champion.

Sunpath H, Hatlen TJ, Naidu KK, Msimango P, Adams RN, Moosa MS, Marconi VC, Murphy RA, Gandhi RT, Pillay S, Siedner M, Naidoo K.

Public Health Action. 2018 Dec 21;8(4):225-231. doi: 10.5588/pha.18.0063.

6.

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.

Adams RN, Tanenbaum ML, Hanes SJ, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

Diabetes Technol Ther. 2018 Oct;20(10):648-653. doi: 10.1089/dia.2018.0174. Epub 2018 Sep 21.

PMID:
30239219
7.

From Wary Wearers to d-Embracers: Personas of Readiness to Use Diabetes Devices.

Tanenbaum ML, Adams RN, Iturralde E, Hanes SJ, Barley RC, Naranjo D, Hood KK.

J Diabetes Sci Technol. 2018 Nov;12(6):1101-1107. doi: 10.1177/1932296818793756. Epub 2018 Aug 22.

8.

Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption.

Tanenbaum ML, Adams RN, Lanning MS, Hanes SJ, Agustin BI, Naranjo D, Hood KK.

J Diabetes Sci Technol. 2018 Nov;12(6):1108-1115. doi: 10.1177/1932296818786486. Epub 2018 Jul 11.

9.

Revisiting the P-36 oil rig accident 15 years later: from management of incidental and accidental situations to organizational factors.

Figueiredo MG, Alvarez D, Adams RN.

Cad Saude Publica. 2018 Mar 29;34(4):e00034617. doi: 10.1590/0102-311X00034617. English, Portuguese.

10.

Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM.

Sci Data. 2017 Dec 5;4:170183. doi: 10.1038/sdata.2017.183.

11.

Adapting and validating a measure of diabetes-specific self-compassion.

Tanenbaum ML, Adams RN, Gonzalez JS, Hanes SJ, Hood KK.

J Diabetes Complications. 2018 Feb;32(2):196-202. doi: 10.1016/j.jdiacomp.2017.10.009. Epub 2017 Oct 26.

PMID:
29157869
12.

Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients.

Adams RN, Mosher CE, Winger JG, Abonour R, Kroenke K.

J Behav Med. 2018 Apr;41(2):243-252. doi: 10.1007/s10865-017-9892-5. Epub 2017 Oct 5.

13.

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa.

Naidoo K, Hassan-Moosa R, Yende-Zuma N, Govender D, Padayatchi N, Dawood H, Adams RN, Govender A, Chinappa T, Abdool-Karim S, Abdool-Karim Q.

PLoS One. 2017 Sep 13;12(9):e0184124. doi: 10.1371/journal.pone.0184124. eCollection 2017.

14.

Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics.

Iturralde E, Adams RN, Barley RC, Bensen R, Christofferson M, Hanes SJ, Maahs DM, Milla C, Naranjo D, Shah AC, Tanenbaum ML, Veeravalli S, Park KT, Hood KK.

J Adolesc Health. 2017 Nov;61(5):591-598. doi: 10.1016/j.jadohealth.2017.05.030. Epub 2017 Aug 19.

PMID:
28830798
15.

Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use.

Tanenbaum ML, Adams RN, Hanes SJ, Barley RC, Miller KM, Mulvaney SA, Hood KK.

J Diabetes Sci Technol. 2017 May;11(3):484-492. doi: 10.1177/1932296816688010. Epub 2017 Jan 10.

16.

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.

Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS, Dent MH, Fortina P, Reynolds CP, Maris JM.

Sci Data. 2017 Mar 28;4:170033. doi: 10.1038/sdata.2017.33. Erratum in: Sci Data. 2017 Dec 05;4:170183.

17.

The Cancer Loneliness Scale and Cancer-related Negative Social Expectations Scale: development and validation.

Adams RN, Mosher CE, Rand KL, Hirsh AT, Monahan PO, Abonour R, Kroenke K.

Qual Life Res. 2017 Jul;26(7):1901-1913. doi: 10.1007/s11136-017-1518-4. Epub 2017 Feb 24.

18.

Relationship Between Depressive Symptoms and Social Cognitive Processing in Partners of Long-Term Breast Cancer Survivors.

Cohee AA, Adams RN, Fife BL, Von Ah DM, Monahan PO, Zoppi KA, Cella D, Champion VL.

Oncol Nurs Forum. 2017 Jan 1;44(1):44-51.

19.

Positive changes among patients with advanced colorectal cancer and their family caregivers: a qualitative analysis.

Mosher CE, Adams RN, Helft PR, O'Neil BH, Shahda S, Rattray NA, Champion VL.

Psychol Health. 2017 Jan;32(1):94-109. Epub 2016 Oct 24.

20.

Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors.

Adams RN, Mosher CE, Cohee AA, Stump TE, Monahan PO, Sledge GW Jr, Cella D, Champion VL.

Psychooncology. 2017 Jul;26(7):982-990. doi: 10.1002/pon.4119. Epub 2016 Mar 10.

21.

Cognitive and Situational Precipitants of Loneliness Among Patients With Cancer: A Qualitative Analysis.

Adams RN, Mosher CE, Abonour R, Robertson MJ, Champion VL, Kroenke K.

Oncol Nurs Forum. 2016 Mar;43(2):156-63. doi: 10.1188/16.ONF.156-163.

22.

Factors associated with depressive symptoms in young long-term breast cancer survivors.

Cohee AA, Stump T, Adams RN, Johns SA, Von Ah D, Zoppi K, Fife B, Monahan PO, Cella D, Champion VL.

Qual Life Res. 2016 Aug;25(8):1991-7. doi: 10.1007/s11136-016-1241-6. Epub 2016 Feb 16.

23.

Family caregiving challenges in advanced colorectal cancer: patient and caregiver perspectives.

Mosher CE, Adams RN, Helft PR, O'Neil BH, Shahda S, Rattray NA, Champion VL.

Support Care Cancer. 2016 May;24(5):2017-2024. doi: 10.1007/s00520-015-2995-z. Epub 2015 Nov 4.

24.

Long-term fear of recurrence in young breast cancer survivors and partners.

Cohee AA, Adams RN, Johns SA, Von Ah D, Zoppi K, Fife B, Monahan PO, Stump T, Cella D, Champion VL.

Psychooncology. 2017 Jan;26(1):22-28. doi: 10.1002/pon.4008. Epub 2015 Oct 21.

25.

Relations of meaning in life and sense of coherence to distress in cancer patients: a meta-analysis.

Winger JG, Adams RN, Mosher CE.

Psychooncology. 2016 Jan;25(1):2-10. doi: 10.1002/pon.3798. Epub 2015 Mar 18. Review.

26.

A meta-analysis of the relationship between social constraints and distress in cancer patients.

Adams RN, Winger JG, Mosher CE.

J Behav Med. 2015 Apr;38(2):294-305. doi: 10.1007/s10865-014-9601-6. Epub 2014 Sep 28. Review.

27.

Cancer survivors' uptake and adherence in diet and exercise intervention trials: an integrative data analysis.

Adams RN, Mosher CE, Blair CK, Snyder DC, Sloane R, Demark-Wahnefried W.

Cancer. 2015 Jan 1;121(1):77-83. doi: 10.1002/cncr.28978. Epub 2014 Aug 25.

28.

Caregiving experiences predict changes in spiritual well-being among family caregivers of cancer patients.

Adams RN, Mosher CE, Cannady RS, Lucette A, Kim Y.

Psychooncology. 2014 Oct;23(10):1178-84. doi: 10.1002/pon.3558. Epub 2014 May 17.

29.

Physical function and quality of well-being in fibromyalgia: the applicability of the goodness-of-fit hypothesis.

Santoro MS, Van Liew C, Cronan TA, Franks HM, Adams RN, Roesch SC, Wooldridge JS, Tomita M.

Health Psychol Behav Med. 2014 Jan 1;2(1):496-508. Epub 2014 Apr 28.

30.

Fibromyalgia and hysterectomy: the impact on health status and health care costs.

Santoro MS, Cronan TA, Adams RN, Kothari DJ.

Clin Rheumatol. 2012 Nov;31(11):1585-9. doi: 10.1007/s10067-012-2051-z. Epub 2012 Aug 9.

PMID:
22875702
31.

Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategy.

Sun W, Adams RN, Miagkov A, Lu Y, Juon HS, Drachman DB.

J Neuroimmunol. 2012 Oct 15;251(1-2):25-32. doi: 10.1016/j.jneuroim.2012.06.007. Epub 2012 Jul 5.

PMID:
22769060
32.

Strategy for treating motor neuron diseases using a fusion protein of botulinum toxin binding domain and streptavidin for viral vector access: work in progress.

Drachman DB, Adams RN, Balasubramanian U, Lu Y.

Toxins (Basel). 2010 Dec;2(12):2872-89. doi: 10.3390/toxins2122872. Epub 2010 Dec 20.

33.

Social anthropology in INCAP.

Adams RN.

Food Nutr Bull. 2010 Mar;31(1):152-60.

PMID:
20461912
34.

Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis.

Drachman DB, Adams RN, Hu R, Jones RJ, Brodsky RA.

Ann N Y Acad Sci. 2008;1132:305-14. doi: 10.1196/annals.1405.033.

35.

Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.

Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB.

Muscle Nerve. 2004 Jul;30(1):55-60.

PMID:
15221879
36.

Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy.

Drachman DB, Wu JM, Miagkov A, Williams MA, Adams RN, Wu B.

Ann N Y Acad Sci. 2003 Sep;998:520-32.

PMID:
14592923
37.

Production and characterization of a T cell receptor transgenic mouse recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.

Miagkov A, Lobito AA, Yang B, Lopes MF, Adams RN, Palardy GR, Johnson MM, McFarland H, Lenardo MJ, Drachman DB.

Ann N Y Acad Sci. 2003 Sep;998:379-83. No abstract available.

PMID:
14592900
38.

T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.

Lobito AA, Yang B, Lopes MF, Miagkov A, Adams RN, Palardy GR, Johnson MM, McFarland HI, Recher M, Drachman DB, Lenardo MJ.

Eur J Immunol. 2002 Jul;32(7):2055-67.

39.

Specific immunotherapy of experimental myasthenia gravis in vitro: the "guided missile" strategy.

Wu JM, Wu B, Miagkov A, Adams RN, Drachman DB.

Cell Immunol. 2001 Mar 15;208(2):137-47.

PMID:
11333146
40.

Specific immunotherapy by genetically engineered APCs: the "guided missile" strategy.

Wu B, Wu JM, Miagkov A, Adams RN, Levitsky HI, Drachman DB.

J Immunol. 2001 Apr 1;166(7):4773-9.

41.

Three-dimensional mapping of norepinephrine and serotonin in human thalamus.

Oke AF, Carver LA, Gouvion CM, Adams RN.

Brain Res. 1997 Jul 18;763(1):69-78.

PMID:
9272830
42.

Oral tolerance in myasthenia gravis.

Drachman DB, Okumura S, Adams RN, McIntosh KR.

Ann N Y Acad Sci. 1996 Feb 13;778:258-72. Review.

PMID:
8610979
43.

Cholinergic stimulation of skeletal muscle cells induces rapid immediate early gene expression: role of intracellular calcium.

Abu-Shakra SR, Cole AJ, Adams RN, Drachman DB.

Brain Res Mol Brain Res. 1994 Oct;26(1-2):55-60.

PMID:
7854066
44.

In vivo dynamics of norepinephrine release-reuptake in multiple terminal field regions of rat brain.

Mitchell K, Oke AF, Adams RN.

J Neurochem. 1994 Sep;63(3):917-26.

PMID:
8051568
45.

A novel therapy for myasthenia gravis by reducing the endocytosis of acetylcholine receptors.

Kuncl RW, Wittstein I, Adams RN, Wiggins WW, Avila O, Pestronk A, McIntosh K, Lucas D, DeSilva S, Lehar M, et al.

Ann N Y Acad Sci. 1993 Jun 21;681:298-302. No abstract available.

PMID:
8357175
47.
48.
49.

Intracerebral infusion of DOPAC decreases striatal dopamine.

Shiekhattar R, Ghasemzadeh MB, Adams RN.

Brain Res Bull. 1992 Dec;29(6):891-6.

PMID:
1473020
50.

Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects.

Oke AF, Putz C, Adams RN, Bird ED.

Psychiatry Res. 1992 Dec;45(4):203-8.

PMID:
1363335

Supplemental Content

Loading ...
Support Center